{"title":"Testicular implants and inflatable vaginal stents – temporary suspension of the CE certificate","public_updated_at":"2015-10-15T14:43:39Z","details":{"metadata":{"alert_type":"devices","issued_date":"2015-10-15","medical_specialism":["cosmetic-surgery","general-surgery","obstetrics-gynaecology","paediatrics","theatre-practitioners","urology"],"bulk_published":false,"document_type":"medical_safety_alert"},"change_history":[{"public_timestamp":"2015-10-15T14:43:39Z","note":"First published."}],"body":"<h2 id=\"action\">Action</h2>\n\n<ul>\n  <li>Do not implant affected devices</li>\n  <li>Quarantine devices</li>\n  <li>Await further advice from the manufacturer and/or MHRA </li>\n  <li>If patients enquire they can be reassured that this situation is being investigated as a matter of priority with our European counterparts to decide on further action. However, if they would like to be kept up to date they can register for <a rel=\"external\" href=\"https://public.govdelivery.com/accounts/UKMHRA/subscriber/new?topic_id=UKMHRA_2143\">email updates</a> and they will be kept informed. </li>\n</ul>\n\n<h4 id=\"deadlines-for-actions\">Deadlines for actions</h4>\n\n<p>Actions underway: 22 October 2015, actions complete: 29 October 2015</p>\n\n<h2 id=\"device-details\">Device details</h2>\n\n<p>All batches of the following devices manufactured by Coloplast A/S are affected:</p>\n\n<p>Testicular implants, product codes: PR3001, PR3002, PR3003, PR3004, PR3005</p>\n\n<p>Vaginal stents – inflatable, product codes: VS3020, VS3022, VS3024, VS3026</p>\n\n<h2 id=\"problembackground\">Problem/background</h2>\n\n<p>The German medical device regulatory authority informed MHRA on Friday 18 September 2015 that a German notified body had temporarily suspended the marketing and distribution of all medical devices manufactured by Silimed lndustria de lmplantes Ltda. </p>\n\n<p>A recent inspection of the manufacturing facility by the notified body identified particles on the surface of some devices. See MHRA’s alert <a href=\"https://www.gov.uk/drug-device-alerts/implantable-medical-devices-manufactured-by-silimed-temporary-suspension-of-the-ce-certificate\">MDA/2015/034</a> published on Friday 25 September 2015.</p>\n\n<p>It has subsequently been established that testicular implants and vaginal stents manufactured by Coloplast A/S are made under sub-contract by Silimed lndustria de lmplantes Ltda and so are also affected by the temporary suspension. </p>\n\n<p>MHRA is investigating in collaboration with other European regulators and recommends that none of these devices should be implanted until further advice is issued.</p>\n\n<p>The manufacturer issued a <a rel=\"external\" href=\"https://mhra.filecamp.com/public/file/2bnv-spukus97\">field safety notice (FSN) dated 9 October 2015</a>. </p>\n\n<h2 id=\"manufacturer-contact\">Manufacturer contact</h2>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nColoplast A/S\n<br />Tina Gotschalk\n<br />Holtedam 1\n<br />Humlebæk\n<br />3050\n<br />Denmark\n<br />\n</p></div></div>\n\n<p>Telephone: +45 4911 3339</p>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#118;&#105;&#103;&#105;&#108;&#097;&#110;&#099;&#101;&#064;&#099;&#111;&#108;&#111;&#112;&#108;&#097;&#115;&#116;&#046;&#099;&#111;&#109;\">&#118;&#105;&#103;&#105;&#108;&#097;&#110;&#099;&#101;&#064;&#099;&#111;&#108;&#111;&#112;&#108;&#097;&#115;&#116;&#046;&#099;&#111;&#109;</a></p>\n\n<h2 id=\"distribution\">Distribution</h2>\n\n<p>If you are responsible for cascading these alerts in your organisation, these are our suggested distribution lists.</p>\n\n<h4 id=\"trusts-nhs-boards-in-scotland\">Trusts (NHS boards in Scotland)</h4>\n\n<p>CAS and SABS (NI) liaison officers for onward distribution to all relevant staff including: </p>\n\n<ul>\n  <li>Cosmetic surgeons </li>\n  <li>Day surgery units </li>\n  <li>Dermatologists </li>\n  <li>General surgeons </li>\n  <li>General surgery </li>\n  <li>General surgical units, directors of </li>\n  <li>Gynaecologists </li>\n  <li>Gynaecology departments </li>\n  <li>Gynaecology nurses </li>\n  <li>Medical device safety officers </li>\n  <li>Medical directors </li>\n  <li>Obstetricians </li>\n  <li>Obstetrics and gynaecology departments </li>\n  <li>Obstetrics and gynaecology directors </li>\n  <li>Obstetrics departments </li>\n  <li>Obstetrics nurses </li>\n  <li>Paediatric surgeons </li>\n  <li>Paediatric surgery, directors of </li>\n  <li>Plastic and reconstructive surgeons</li>\n  <li>Risk managers </li>\n  <li>Supplies managers </li>\n  <li>Theatre managers </li>\n  <li>Theatre nurses </li>\n  <li>Theatres </li>\n  <li>Urological surgeons </li>\n  <li>Urological surgery, directors of </li>\n  <li>Urology departments</li>\n</ul>\n\n<h4 id=\"establishments-registered-with-the-care-quality-commission-cqc-england-only\">Establishments registered with the Care Quality Commission (CQC) (England only)</h4>\n\n<ul>\n  <li>Hospitals in the independent sector</li>\n  <li>Independent treatment centres</li>\n  <li>Private medical practitioners</li>\n</ul>\n\n<p>Please note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health’s Central Alerting System (CAS) by sending an email to: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#115;&#097;&#102;&#101;&#116;&#121;&#097;&#108;&#101;&#114;&#116;&#115;&#064;&#100;&#104;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#115;&#097;&#102;&#101;&#116;&#121;&#097;&#108;&#101;&#114;&#116;&#115;&#064;&#100;&#104;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a> and requesting this facility.</p>\n\n<h2 id=\"enquiries\">Enquiries</h2>\n\n<h3 id=\"england\">England</h3>\n\n<p>Send enquiries about this notice to MHRA, quoting reference number MDA/2015/036 or 2015/010/009/299/003 </p>\n\n<h4 id=\"technical-aspects\">Technical aspects</h4>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nIan Smith or Bayode Adisa\n<br />MHRA\n<br />\n</p></div></div>\n\n<p>Telephone: 020 3080 7306 / 7723</p>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#105;&#097;&#110;&#046;&#115;&#109;&#105;&#116;&#104;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#105;&#097;&#110;&#046;&#115;&#109;&#105;&#116;&#104;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a> or  <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#098;&#097;&#121;&#111;&#100;&#101;&#046;&#097;&#100;&#105;&#115;&#097;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#098;&#097;&#121;&#111;&#100;&#101;&#046;&#097;&#100;&#105;&#115;&#097;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a> </p>\n\n<h4 id=\"clinical-aspects\">Clinical aspects</h4>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nDr S Jagdish\n<br />MHRA \n<br />\n</p></div></div>\n\n<p>Telephone: 020 3080 7187 </p>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#115;&#111;&#117;&#110;&#100;&#097;&#114;&#097;&#114;&#097;&#106;&#097;&#110;&#046;&#106;&#097;&#103;&#100;&#105;&#115;&#104;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#115;&#111;&#117;&#110;&#100;&#097;&#114;&#097;&#114;&#097;&#106;&#097;&#110;&#046;&#106;&#097;&#103;&#100;&#105;&#115;&#104;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a></p>\n\n<h4 id=\"reporting-adverse-incidents-in-england\">Reporting adverse incidents in England</h4>\n\n<p><a rel=\"external\" href=\"https://yellowcard.mhra.gov.uk/\">Through Yellow Card</a> </p>\n\n<h3 id=\"northern-ireland\">Northern Ireland</h3>\n\n<p>Alerts in Northern Ireland are distributed via the <a rel=\"external\" href=\"http://sabs.dhsspsni.gov.uk/\">NI SABS system</a>.</p>\n\n<p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nNorthern Ireland Adverse Incident Centre\n<br />CMO Group, \n<br />Department of Health, Social Services and Public Safety\n<br />\n</p></div></div>\n\n<p>Telephone: 028 9052 3868</p>\n\n<p>Fax:\t028 9052 3900</p>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#078;&#073;&#065;&#073;&#067;&#064;&#100;&#104;&#115;&#115;&#112;&#115;&#110;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#078;&#073;&#065;&#073;&#067;&#064;&#100;&#104;&#115;&#115;&#112;&#115;&#110;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a></p>\n\n<p><a rel=\"external\" href=\"http://www.dhsspsni.gov.uk/index/hea/niaic.htm\">Northern Ireland Adverse Incident Centre (NIAIC)</a></p>\n\n<h4 id=\"reporting-adverse-incidents-in-northern-ireland\">Reporting adverse incidents in Northern Ireland</h4>\n\n<p>Please report directly to NIAIC using the <a rel=\"external\" href=\"http://www.dhsspsni.gov.uk/index/phealth/niaic/niaic_reporting_incidents.htm\">forms on our website</a>.</p>\n\n<h3 id=\"scotland\">Scotland</h3>\n\n<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nIncident Reporting and Investigation Centre\n<br />Health Facilities Scotland\n<br />NHS National Services Scotland \n<br />\n</p></div></div>\n\n<p>Telephone: 0131 275 7575\t</p>\n\n<p>Fax:\t0131 314 0722</p>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#110;&#115;&#115;&#046;&#105;&#114;&#105;&#099;&#064;&#110;&#104;&#115;&#046;&#110;&#101;&#116;\">&#110;&#115;&#115;&#046;&#105;&#114;&#105;&#099;&#064;&#110;&#104;&#115;&#046;&#110;&#101;&#116;</a></p>\n\n<h4 id=\"reporting-adverse-incidents-in-scotland\">Reporting adverse incidents in Scotland</h4>\n\n<p>NHS Boards and Local Authorities in Scotland – <a rel=\"external\" href=\"http://www.hfs.scot.nhs.uk/services/incident-reporting-and-investigation-centre-iric/how-to-report-an-adverse-incident/\">report to Health Facilities Scotland</a>.  </p>\n\n<p>Contractors such as private hospitals carrying out NHS work and private care homes that accept social work funded clients – <a rel=\"external\" href=\"http://www.hfs.scot.nhs.uk/services/incident-reporting-and-investigation-centre-iric/how-to-report-an-adverse-incident/\">report to Health Facilities Scotland</a>.</p>\n\n<p>Private facilities providing care to private clients report to the <a rel=\"external\" href=\"http://www.careinspectorate.com/\">Care Inspectorate</a> and <a rel=\"external\" href=\"https://yellowcard.mhra.gov.uk/\">MHRA</a>.</p>\n\n<h3 id=\"wales\">Wales</h3>\n\n<p>Enquiries in Wales should be addressed to:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nHealthcare Quality Division\n<br />Welsh Government\n<br />\n</p></div></div>\n\n<p>Telephone: 02920 823 624/02920 825 510</p>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#072;&#097;&#122;&#045;&#065;&#105;&#099;&#064;&#119;&#097;&#108;&#101;&#115;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#072;&#097;&#122;&#045;&#065;&#105;&#099;&#064;&#119;&#097;&#108;&#101;&#115;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a></p>\n\n<h4 id=\"reporting-adverse-incidents-in-wales\">Reporting adverse incidents in Wales</h4>\n\n<p>Report to MHRA through <a rel=\"external\" href=\"https://yellowcard.mhra.gov.uk/\">Yellow Card</a> and follow specific advice for reporting in Wales in <a rel=\"external\" href=\"http://www.wales.nhs.uk/sites3/page.cfm?orgid=465&amp;pid=56203\">MDA/2004/054 (Wales)</a>.</p>\n\n<h2 id=\"download-document\">Download document</h2>\n\n<p><a rel=\"external\" href=\"https://assets.digital.cabinet-office.gov.uk/media/561fa16140f0b6585f000013/Testicular_implants_and_inflatable_vaginal_stents___temporary_suspension_of_the_CE_certificate_MDA-2015-036_.pdf\">Testicular implants and inflatable vaginal stents – temporary suspension of the CE certificate MDA-2015-036 </a></p>\n\n","headers":[{"text":"Action","level":2,"id":"action"},{"text":"Device details","level":2,"id":"device-details"},{"text":"Problem/background","level":2,"id":"problembackground"},{"text":"Manufacturer contact","level":2,"id":"manufacturer-contact"},{"text":"Distribution","level":2,"id":"distribution"},{"text":"Enquiries","level":2,"id":"enquiries","headers":[{"text":"England","level":3,"id":"england","headers":[{"text":"Technical aspects","level":4,"id":"technical-aspects"},{"text":"Clinical aspects","level":4,"id":"clinical-aspects"},{"text":"Reporting adverse incidents in England","level":4,"id":"reporting-adverse-incidents-in-england"}]},{"text":"Northern Ireland","level":3,"id":"northern-ireland","headers":[{"text":"Reporting adverse incidents in Northern Ireland","level":4,"id":"reporting-adverse-incidents-in-northern-ireland"}]},{"text":"Scotland","level":3,"id":"scotland","headers":[{"text":"Reporting adverse incidents in Scotland","level":4,"id":"reporting-adverse-incidents-in-scotland"}]},{"text":"Wales","level":3,"id":"wales","headers":[{"text":"Reporting adverse incidents in Wales","level":4,"id":"reporting-adverse-incidents-in-wales"}]}]},{"text":"Download document","level":2,"id":"download-document"}]},"routes":[{"path":"/drug-device-alerts/testicular-implants-and-inflatable-vaginal-stents-temporary-suspension-of-the-ce-certificate","type":"exact"}],"redirects":[],"publishing_app":"specialist-publisher","rendering_app":"government-frontend","need_ids":[],"phase":"live","analytics_identifier":null,"document_type":"medical_safety_alert","schema_name":"specialist_document","first_published_at":"2016-02-29T09:24:10Z","base_path":"/drug-device-alerts/testicular-implants-and-inflatable-vaginal-stents-temporary-suspension-of-the-ce-certificate","description":"Manufactured by Coloplast A/S – temporary suspension of the CE certificate due to particles found on some implantable devices made by their subcontractor Silimed lndustria de lmplantes Ltda - MDA/2015/036","content_id":"5ee3d740-8056-4a21-940f-a6580a4e95d4","locale":"en","expanded_links":{"organisations":[{"analytics_identifier":"EA63","api_path":"/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency","base_path":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","description":null,"document_type":"organisation","locale":"en","public_updated_at":"2015-06-29T14:33:29Z","schema_name":"placeholder","title":"Medicines and Healthcare products Regulatory Agency","withdrawn":false,"details":{"brand":"department-of-health","logo":{"formatted_title":"Medicines &amp; Healthcare products<br/>Regulatory Agency","crest":"single-identity"}},"links":{}}],"finder":[{"analytics_identifier":null,"api_path":"/api/content/drug-device-alerts","base_path":"/drug-device-alerts","content_id":"1e9c0ada-5f7e-43cc-a55f-cc32757edaa3","description":"Find alerts and recalls issued by MHRA","document_type":"finder","locale":"en","public_updated_at":"2017-03-30T10:34:00Z","schema_name":"finder","title":"Alerts and recalls for drugs and medical devices","withdrawn":false,"details":{"document_noun":"alert","filter":{"document_type":"medical_safety_alert"},"format_name":"Medical safety alert","show_summaries":true,"facets":[{"key":"alert_type","name":"Alert type","type":"text","preposition":"for","display_as_result_metadata":true,"filterable":true,"allowed_values":[{"label":"Drug alert","value":"drugs"},{"label":"Medical device alert","value":"devices"},{"label":"Field safety notice","value":"field-safety-notices"},{"label":"Drug alert: company-led","value":"company-led-drugs"}]},{"key":"medical_specialism","name":"Medical specialism","type":"text","preposition":"about","display_as_result_metadata":true,"filterable":true,"allowed_values":[{"label":"Anaesthetics","value":"anaesthetics"},{"label":"Cardiology","value":"cardiology"},{"label":"Care home staff","value":"care-home-staff"},{"label":"Cosmetic surgery","value":"cosmetic-surgery"},{"label":"Critical care","value":"critical-care"},{"label":"Dentistry","value":"dentistry"},{"label":"General practice","value":"general-practice"},{"label":"General surgery","value":"general-surgery"},{"label":"Haematology and oncology","value":"haematology-oncology"},{"label":"Infection prevention","value":"infection-prevention"},{"label":"Obstetrics and gynaecology","value":"obstetrics-gynaecology"},{"label":"Ophthalmology","value":"ophthalmology"},{"label":"Orthopaedics","value":"orthopaedics"},{"label":"Paediatrics","value":"paediatrics"},{"label":"Pathology","value":"pathology"},{"label":"Pharmacy","value":"pharmacy"},{"label":"Physiotherapy and occupational therapy","value":"physiotherapy-occupational-therapy"},{"label":"Radiology","value":"radiology"},{"label":"Renal medicine","value":"renal-medicine"},{"label":"Theatre practitioners","value":"theatre-practitioners"},{"label":"Urology","value":"urology"},{"label":"Vascular and cardiac surgery","value":"vascular-cardiac-surgery"}]},{"key":"issued_date","name":"Issued","short_name":"Issued","type":"date","preposition":"issued","display_as_result_metadata":true,"filterable":true}],"default_documents_per_page":50},"links":{}}],"available_translations":[{"title":"Testicular implants and inflatable vaginal stents – temporary suspension of the CE certificate","public_updated_at":"2015-10-15T14:43:39Z","analytics_identifier":null,"document_type":"medical_safety_alert","schema_name":"specialist_document","base_path":"/drug-device-alerts/testicular-implants-and-inflatable-vaginal-stents-temporary-suspension-of-the-ce-certificate","description":"Manufactured by Coloplast A/S – temporary suspension of the CE certificate due to particles found on some implantable devices made by their subcontractor Silimed lndustria de lmplantes Ltda - MDA/2015/036","api_path":"/api/content/drug-device-alerts/testicular-implants-and-inflatable-vaginal-stents-temporary-suspension-of-the-ce-certificate","withdrawn":false,"content_id":"5ee3d740-8056-4a21-940f-a6580a4e95d4","locale":"en"}]},"format":"specialist_document","navigation_document_supertype":"other","user_journey_document_supertype":"thing","email_document_supertype":"other","government_document_supertype":"other","payload_version":0}